NAFDAC Bans Registration of Multi-Dose Artemether/Lumefantrine Oral Suspension Due to Safety Concerns
Official Public Notice from NAFDAC The National Agency for Food and Drug Administration and Control (NAFDAC) has issued an important update regarding the safety and regulatory status of Multi-Dose Artemether/Lumefantrine dry powder for oral suspension, a commonly used anti-malarial medication in Nigeria. Following stability testing and product evaluations, NAFDAC has officially discontinued the registration and […]
